Headache Specialist Pharmacist Mat Garrod presenting on high cost drugs and how pharmacists can help in supporting headache pathways @TheNeuroAcademy #neuropharmacy @UKCPANeuro @MigraineTrust
Very excited to be heading into 2 days of discussion around improving headache services in the NHS @TheNeuroAcademy
Proud to have been at the House of Commons today. Looking at ways to remove barriers to MS care. Thanks to @linaruns for sharing her story. Specialist pharmacists have an important role to play in better access to MS care @ms_trust @shiftdotms @UKCPANeuro
Late breaking #ECTRIMS2025
Combination of metformin and clemastine shows a positive effect on remyelination but not clinically significant. More studies needed
Late breaking #ECTRIMS2025
Swedish RIDOSE study shows that RTX 500mg every 12 months is as effective as 6 monthly doses in maintaining NEDA
Late Breaking #ECTRIMS2025
Higher body weight doses of ocrelizumab did not reduce progression in PPMS
Late Breaking #ECTRIMS2025. Prof Giovannoni presents the first study demonstrating the benefit of a DMT (ocrelizumab) in pwMS who are EDSS > 6.5
Today is World Pharmacists Day! Celebrating the contribution of pharmacists at #ECTRIMS2025 with a record number of neuropharmacists in attendance @UKCPANeuro @UKNeuroPharmacy
Great talks in the session on managing risks of HET #ECTRIMS2025. Lots of work going on looking at alternative dosing regimes of B cell therapies. Looking forward to seeing outcomes of the BLOOM study comparing standard to B cell guided dosing ….@UKCPANeuro @UKNeuroPharmacy
Getting ready for day 2 at #ECTRIMS2025.
Heading your way the session on personalised treatment regimes in #MS. See you there?
#neuropharmacists
@UKNeuroPharmacy @UKCPANeuro
Check out our e-poster on the evolving role of the #Pharmacist in the #MS team. P1642.
#ECTRIMS2025
@ImperialNHS @UKCPANeuro
@UKNeuroPharmacy
Here we go! #ECTRIMS2025 has kicked off in Barcelona. Very excited that we have at least 14 neuropharmacists attending from the UK this year! Highlighting the growing recognition of the contribution #pharmacists can make to #MS care @UKCPANeuro @UKNeuroPharmacy
Some thoughts on the natalizumab biosimilar roll out. Good to reflect on what could be done differently as we move into an era of further biosimilars & generics in the MS space
pn.bmj.com/content/practneur…
Ray Dorsey retweeted
We've just completed our 3rd #Neuropharmacy MasterClass, where delegates presented the outcomes of their workplace projects. Inspiring to see such dedication to improving services and patient care in local settings! Read more: eu1.hubs.ly/H0mnGSs0
@UKNeuroPharmacy
Ray Dorsey retweeted
Pharmacy technicians and pharmacists – have you seen our email about the @MHRAgovuk valproate Drug Safety Update and updated safety and educational materials? You can also find this on our website >> tinyurl.com/zfrp3aay
Today at the Neuropharmacy academy we have a masterclass on epilepsy delivered by Dr Stephen Auger @TheNeuroAcademy @UKNeuroPharmacy
Ray Dorsey retweeted
Massive congratulations - Neuropharmacist Masterclass project winners Emma and Tyler! @TheNeuroAcademy @steespharmacy
Started the day with a 5k! @TheNeuroAcademy
All ready for a day of learning on epilepsy
#neuropharmacy @UKNeuroPharmacy
Wrapped up today with a fantastic poster session. Delegates presented a range of fantastic audit and service development projects undertaken in their neurology services
@TheNeuroAcademy
@UKNeuroPharmacy
@UKCPANeuro
@joelamathews





















